Showing results (101-110 of 120) with videos related to
Sort By:
Pageof 12
The Lancet. Oncology|March 6, 2017
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trialRuth Ladenstein, Ulrike Pötschger, Andrew D J Pearson, et al.Cancer Cell|July 14, 2012
The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastomaTeeara Berry, William Luther, Namrata Bhatnagar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2023
Combination Early-Phase Trials of Anticancer Agents in Children and AdolescentsLucas Moreno, Steven G DuBois, Julia Glade Bender, et al.JCO Precision Oncology|January 15, 2026
Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder AnalysisSusanne A Gatz, Julia Glade-Bender, Andrew D J Pearson, et al.Journal of the National Cancer Institute|August 25, 2025
International neuroblastoma risk group consortium: a model of a networking for rare cancersSusan L Cohn, Wendy B London, Gudrun Schleiermacher, et al.European Journal of Cancer (Oxford, England : 1990)|August 1, 2025
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC studyFernando Carceller, Francisco Bautista, Harm Van Tinteren, et al.European Journal of Cancer (Oxford, England : 1990)|February 18, 2019
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in childrenAndrew D J Pearson, Nicole Scobie, Koenraad Norga, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2020
Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN StudyKeith Holmes, Ulrike Pötschger, Andrew D J Pearson, et al.European Journal of Cancer (Oxford, England : 1990)|July 13, 2020
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe NeuroblastomaLucas Moreno, Giuseppe Barone, Steven G DuBois, et al.European Journal of Cancer (Oxford, England : 1990)|July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew D J Pearson, Sara Federico, Susanne A Gatz, et al.Pageof 12